Skip to content
drillr.ai
Sign up

ENSG

The Ensign Group, Inc.

NASDAQ · Healthcare · Medical - Care Facilities · US

$170.79
−0.76%
Ask drillr

Research · Sep 3, 2026

[ENSG] Ensign Group Thesis 2026: Skilled Nursing Cycle Drives De Novo Same-Facility Capital Return

The Ensign Group, Inc. (NASDAQ: ENSG) FY2025 revenue ~$4.85-5.10B (+15-22%) with adj. EPS ~$5.95-6.45 reflecting continued post-2024 ~$4.45-4.65B aggregate Skilled Nursing + Senior Living revenue (~92%+ aggregate revenue mix; selected primary 14-state US Skilled Nursing Facility (SNF) operator + selected various Senior Living + selected various Standard Bearer real estate segment) + selected continued post-2024 ~$390-440M aggregate Standard Bearer (real estate) revenue (~8% aggregate revenue mix) under continued President + CEO Barry Port since 2019 (~6-year tenure as Ensign Group CEO). One of the largest US Skilled Nursing Facility (SNF) + Senior Living operators. Founded 1999 as Ensign Group by Christopher Christensen + Roy Christensen + Daren Christensen + Gregory Christensen in Mission Viejo California (~26-year heritage); selected post-November 2007 NASDAQ IPO; selected post-October 2019 Pennant Group home health + hospice spinoff separation; selected post-2019 Barry Port CEO appointment. Headquartered in San Juan Capistrano California; ~50,000+ employees globally with ~$4.85-5.10B revenue. Two primary business segments: Skilled Services + Senior Living (~92%+ ~$4.45-4.65B), Standard Bearer Real Estate (~8% ~$390-440M). Geographic mix: US ~100%; selected primary 14-state US footprint (Texas + California + Arizona + Colorado + Idaho + Iowa + Nebraska + Nevada + Utah + Washington). Skilled Nursing cycle (same-facility growth): ~$4.45-4.65B Skilled Nursing + Senior Living revenue; ~330+ aggregate facilities; ~32,000+ aggregate operational beds; ~70-75% aggregate occupancy; ~30-35% aggregate skilled mix; ~+5-7% aggregate same-facility skilled mix growth; ~+8-10% aggregate same-facility revenue growth. De novo + acquisition pipeline (Sun Belt focus): ~30+ aggregate annual de novo + acquisition Skilled Nursing Facility additions; ~$200-300M aggregate annual de novo + acquisition CapEx; ~$300-500M aggregate ongoing acquisition pipeline. President + CEO Barry Port since 2019 (~6-year tenure); CFO Suzanne Snapper. Capital return: ~$0.62 annual dividend FY2025 (~+5-8% growth post-2024 dividend acceleration; ~22-year continuous dividend track post-2002); minimal opportunistic buybacks; aggregate capital return ~$60-100M FY2025; net leverage ratio ~negligible (~debt-free balance sheet); investment-grade BBB+/Baa2 credit rating. FY2026 thesis: Skilled Nursing cycle (same-facility growth) + De novo + acquisition pipeline + ~$0.62 annual dividend + ~22-year continuous dividend track + ~$60-130M aggregate annual capital return + selected potential post-2024 dividend acceleration. Risks: Genesis HealthCare + Brookdale Senior Living + Welltower-leased + Ventas-leased + Healthpeak-leased competition, CMS Skilled Nursing reimbursement, Medicare Advantage payer mix shift, state Medicaid reimbursement, de novo + acquisition integration considerations.

Research · Mar 12, 2026

CMS Proposes 6.4% Home Health Cut — Three Operators Most at Risk

CMS has proposed a 6.4% aggregate payment cut for home health agencies in CY2026, creating material risk for operators with high Medicare home health exposure. Aveanna Healthcare (AVAH) faces the greatest financial risk due to 5.1x debt/EBITDA leverage and thin interest coverage, while Ensign Group (ENSG) is best positioned to absorb the impact given its SNF-dominated revenue mix and strong growth trajectory. Amedisys (AMED), now part of Optum/UnitedHealth, is no longer independently exposed.

Research · Mar 12, 2026

Can home health companies offset the CMS 6.4% cut through volume growth and labor efficiency?

The CMS 6.4% home health payment cut for CY2026 represents a manageable headwind for leading operators. Aveanna Healthcare's 22% revenue growth, expanding preferred payer network of 30 agreements, and EBITDA margin recovery from 2.1% to over 12% provide substantial buffer, while Ensign Group's acquisition-driven 19% growth and all-time high occupancy rates insulate its primarily skilled nursing business. The effective revenue impact — estimated at 2–3% for diversified operators — appears absorbable, though compounding Medicaid rate pressure remains the key risk to watch.

Research · Mar 12, 2026

If CMS finalizes the 6.4% home health payment cut, which operators face the steepest margin compression?

Among publicly traded operators, Aveanna Healthcare (AVAH) faces the steepest margin compression from a potential 6.4% CMS home health payment cut, given its leveraged balance sheet (5.1x debt/EBITDA) and thin free cash flow ($26M), despite home health representing only ~10% of revenue. Ensign Group has minimal direct exposure as a SNF-focused operator, while Sotera Health has no home health revenue and Amedisys was acquired by UnitedHealth in 2024.

Research · Mar 12, 2026

How does Family First Homecare's margin profile compare to Aveanna's existing segments?

Aveanna Healthcare's three segments show wide margin dispersion — PDS at ~29-31% gross margin, HHH at ~54%, and MS at ~45%. Family First Homecare, as a pediatric PDN operator, would flow into the PDS segment and likely carries gross margins in the 28-32% range based on the Thrive Skilled Pediatrics acquisition precedent. The real accretion opportunity lies in leveraging Aveanna's 30 preferred payer agreements and corporate infrastructure to compress the target's standalone SG&A.